| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $396.3M | — | +49.9% |
| Cost of Revenue | $162.4M | — | +57.0% |
| R&D Expense | $45.0M | — | +67.7% |
| SG&A Expense | $73.4M | — | +35.8% |
| Operating Income | -$18.8M | — | -16.9% |
| Interest Expense | $761K | — | +129.9% |
| Pre-tax Income | -$15.8M | — | +20.7% |
| Income Tax | -$2.6M | — | -256.8% |
| Net Income | -$13.2M | — | +38.7% |
| EPS (Basic) | -$0.06 | — | +40.0% |
| EPS (Diluted) | -$0.06 | — | +40.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $288.8M | -9.7% | -20.8% |
| Accounts Receivable | $321.7M | -0.2% | +43.8% |
| Current Assets | $649.3M | -5.3% | +7.9% |
| Total Assets | $1.45B | -3.7% | +33.1% |
| Current Liabilities | $314.2M | -26.8% | +73.8% |
| Long-term Debt | $197.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $49.7M | — | +42.9% |
| Capital Expenditures | $3.0M | — | +10.1% |
| Investing Cash Flow | -$55.6M | — | -648.6% |
| Financing Cash Flow | -$25.7M | — | +12.8% |
| Free Cash Flow | $46.7M | — | +45.7% |
| +0.4% |
| Total Liabilities | $566.9M | -18.9% | +37.9% |
| Stockholders' Equity | $880.3M | +9.4% | +30.1% |